deltatrials
Terminated PHASE1 INTERVENTIONAL 1-arm NCT02201355

Hypofractionated Reduced-Volume Chemoradiation for T1/2N0-2 SCC Head and Neck

A Phase I Study of Reduced-Volume Hypofractionated, PET-directed Intensity Modulated Radiotherapy Concurrent With Weekly Cisplatin Chemotherapy for T1/2N0-2 Squamous Cell Carcinoma of the Head and Neck

Sponsor: University of Texas Southwestern Medical Center

Conditions Squamous Cell Carcinoma of the Head and Neck T1/2N0-2
Interventions Intensity Modulated Radiotherapy
Updated 13 times since 2017 Last updated: Jan 28, 2021 Started: Sep 18, 2014 Primary completion: Jan 23, 2018 Completion: May 15, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

PI LEFT THE DEPARTMENT

Other terminated trials from University of Texas Southwestern Medical Center

See all terminations from University of Texas Southwestern Medical Center

This PHASE1 trial investigates Squamous Cell Carcinoma of the Head and Neck T1/2N0-2 and is currently terminated or withdrawn. University of Texas Southwestern Medical Center leads this study, which shows 13 recorded versions since 2014 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Mar 2018 · 13 months · monthly snapshot~Mar 2018 – ~Apr 2018 · 31 days · monthly snapshot~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshot~Jun 2018 – ~Apr 2019 · 10 months · monthly snapshot~Apr 2019 – ~Apr 2020 · 12 months · monthly snapshot~Apr 2020 – ~Jun 2020 · 2 months · monthly snapshot~Jun 2020 – ~Sep 2020 · 3 months · monthly snapshot~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~Jul 2024 · 40 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

13 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE1

  3. Mar 2021 — Jul 2024 [monthly]

    Terminated PHASE1

    Status: Suspended → Terminated

  4. Jan 2021 — Mar 2021 [monthly]

    Suspended PHASE1

  5. Sep 2020 — Jan 2021 [monthly]

    Suspended PHASE1

▶ Show 8 earlier versions

  1. Jun 2020 — Sep 2020 [monthly]

    Suspended PHASE1

    Status: Active Not Recruiting → Suspended

  2. Apr 2020 — Jun 2020 [monthly]

    Active Not Recruiting PHASE1

  3. Apr 2019 — Apr 2020 [monthly]

    Active Not Recruiting PHASE1

  4. Jun 2018 — Apr 2019 [monthly]

    Active Not Recruiting PHASE1

  5. Apr 2018 — Jun 2018 [monthly]

    Active Not Recruiting PHASE1

    Status: Recruiting → Active Not Recruiting

  6. Mar 2018 — Apr 2018 [monthly]

    Recruiting PHASE1

    Status: Active Not Recruiting → Recruiting

  7. Feb 2017 — Mar 2018 [monthly]

    Active Not Recruiting PHASE1

  8. Jan 2017 — Feb 2017 [monthly]

    Active Not Recruiting PHASE1

    First recorded

Sep 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of Texas Southwestern Medical Center
Data source: University of Texas Southwestern Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations